Vazyme COVID-19

Research Solutions for Coronavirus

Vazyme Solutions for SARS-CoV-2 (2019-nCoV) Detection

Research Solutions for Coronavirus

Product

Virus Sample Stabilizer (with Nasopharyngeal Swab)

Cat#

Size

Introduction

R513-01
R513-02

50 tubes, 1.5 ml / tube
50 tubes, 3 ml / tube

Applicable to specimen collection from human nasopharyngeal swab
specimen and nucleic acid preservation.

Product

FastPure Viral DNA/RNA Mini Kit

Cat#

Size

Introduction

RC311-C1

100 tests / kit

Applicable to specimen collection from plasma, serum, nasopharyngeal swabs, sputum, bronchoalveolar lavage fluid, ascites, supernatant of cultured cell and urine.

Product

2019-Novel Coronavirus (2019-nCoV) Triplex RT-qPCR Detection Kit

Cat#

Size

Introduction

CD302-02

100 tests / kit

1) Adding 20 ul of extracted RNA to increase detection sensitivity and reduce false negatives;

2) Positive control (2019-nCoV-pseudoviruse) provides a nucleic acid extraction and a reverse transcription control to validate the entire procedure and reagent integrity. 3) Internal control (RNAse P gene) provides a nucleic acid extraction procedural control and a secondary
negative control.

Product

2019-Novel Coronavirus (2019-nCoV) IgG / IgM Detection Kit (Colloidal Gold-Based)

Cat#

Size

Introduction

C6603C-02

50 tests / kit

Applicable to detection of 2019-nCoV IgG / IgM antibodies from human whole blood, serum or plasma within 10 min. No instruments needed.

2019-nCoV IgG / IgM Detection Kit (Colloidal Gold-Based)

Rapid detection within 10 min. No equipments required.

Both IgM and IgG are immunoglobulin which are produced by the immune system to provide protection against the 2019-nCoV. Some patients with negative results in nucleic acid test show positive in IgM test, indicating that the IgG / IgM detection is one of the effective methods for the diagnosis of 2019-nCoV.
The level of IgM antibody begins to rise after 1 week after the initial infection, while the IgG appears later than IgM (usually in 14 days after infection) and can last for 6 months or even several years, which means that the IgG serves as an indicator of previous infection. Suspected patients that are infected by 2019-nCoV can be rapidly identified by simultaneous monitoring of IgM and IgG. During the outbreak period of 2003-SARS and the 2016-Zika, IgM / IgG antibody detection was used as one of the recommended diagnostic methods.

Research Solutions for Coronavirus
Product Advantages
  • Rapid-screening within 10 minutes.
  • High detection efficiency: simultaneous monitoring of IgM and IgG.
  • Detection without any equipments.
  • Easy to operate, and is compatible with serum/ whole blood/ plasma.
  • Room-temperature storage.

 

Interpreting Test Results

Research Solutions for Coronavirus
ResultsInterpreting
IgM positive, IgG positiveIndicates that it may be a recent infection with 2019-nCoV.
IgM positive, IgG negativeIndicates that it may be a recent infection with 2019-nCoV.
IgM negative, IgG positiveIndicates that it may be a previous infection with 2019-nCoV.
IgM negative, IgG negativeIndicates that it may be on infection with 2019-nCoV, or there is not enough detectable antibodies in the early infection.
Product Name2019-nCoV IgG / IgM Detection Kit (Colloidal Gold-Based)
Size50 Tests / Kit
SpecimenSerum / Plasma / Whole Blood
Required Volume of Specimen20 ul
Storage4℃ - 30℃. Sealed.
Research Solutions for Coronavirus

SUPPORT

outstanding technical support

Research Solutions for Coronavirus

PRODUCT

we offer a full product guarantee

Research Solutions for Coronavirus

DELIVERY

we offer free delivery to UK universities and non profit organisations